Navigation Links
Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome
Date:1/15/2014

CAMBRIDGE, Mass., Jan. 15, 2014 /PRNewswire/ -- Zafgen, Inc., a leading biopharmaceutical company dedicated to addressing the unmet needs of severely obese patients, today announced initial results from its Phase 2a study of beloranib, a selective inhibitor of methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi syndrome (PWS), a severe form of genetic obesity.  These results showed improvements in body weight, hunger-related behaviors, and body composition, including reductions in body fat content and preserved lean body mass following four weeks of treatment. 

These changes were observed despite the increased caloric intake that was a component of this trial.  Known markers of beloranib response including those associated with cardiovascular disease risk were also improved, demonstrating that PWS patients responded to the molecular mechanism of beloranib.

"The results of this short-term proof-of-concept study are very promising and underscore our belief that beloranib has the potential to successfully treat this severe form of obesity.  To our knowledge, this study represents the largest placebo-controlled, randomized, multiple dose trial to date for obesity in this patient population, and these results bode well for further study of beloranib in patients with this devastating condition," said Thomas Hughes, Ph.D., President and Chief Executive Officer of Zafgen.

Similar to results seen in non-PWS obese patient populations, beloranib treatment in this study reduced body fat content by 8.1% vs. placebo in four weeks of treatment at the highest study dose of 1.8 mg, despite a 50% increased daily caloric allowance.  Hunger-related behaviors improved, and a trend towards overall improvement in body weight was seen, although this did not reach statistical significance, in part due to the fact that study was not powered to demonstrate these differ
'/>"/>

SOURCE Zafgen, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Zafgen Announces Initiation of Phase 2a Clinical Development with Beloranib in Obesity
2. Zafgen Secures $21 Million in Series D Financing
3. Zafgen Announces New Weight Loss and Safety Data from Phase 2 Study of Beloranib in Obesity at Obesity Week 2013
4. Zafgen Secures $45 Million in Series E Financing
5. Zafgen Appoints Chief Commercial Officer and New Member of Board of Directors
6. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
7. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
8. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
9. Misonix Announces New Distribution Agreement For Panama
10. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
11. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 4, 2015  Sangamo BioSciences, Inc. (NASDAQ: SGMO ... Ch.B., Sangamo,s executive vice president, research and development, will ... Therapeutic ® development programs and an overview of ... August 11, 2015, at the 2015 Wedbush Pacgrow Healthcare ... New York, NY . The presentation ...
(Date:8/4/2015)... Aug. 04, 2015 ... the addition of the "MRI Systems Market ... Operational Efficiency, with Growth Driven by Developing Economies" ... Systems Market to 2020 - Focus on Patient ... Developing Economies" discusses the market, competitive landscape, and ...
(Date:8/4/2015)... 2015  Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) ... million for the three and six months ended June ... $12.1 million and $43.4 million for the same periods ... primarily by the more than $90 million of revenue ... upfront payment from Bayer to license  ISIS-FXI Rx .  ...
Breaking Medicine Technology:Sangamo BioSciences Announces Presentation At The 2015 Wedbush Pacgrow Healthcare Conference 2Global MRI Systems Market Outlook to 2020 - Focus on Patient Comfort and Operational Efficiency, with Growth Driven by Developing Economies 2Isis Reports Financial Results And Highlights For Second Quarter 2015 2Isis Reports Financial Results And Highlights For Second Quarter 2015 3Isis Reports Financial Results And Highlights For Second Quarter 2015 4Isis Reports Financial Results And Highlights For Second Quarter 2015 5Isis Reports Financial Results And Highlights For Second Quarter 2015 6Isis Reports Financial Results And Highlights For Second Quarter 2015 7Isis Reports Financial Results And Highlights For Second Quarter 2015 8Isis Reports Financial Results And Highlights For Second Quarter 2015 9Isis Reports Financial Results And Highlights For Second Quarter 2015 10Isis Reports Financial Results And Highlights For Second Quarter 2015 11Isis Reports Financial Results And Highlights For Second Quarter 2015 12Isis Reports Financial Results And Highlights For Second Quarter 2015 13Isis Reports Financial Results And Highlights For Second Quarter 2015 14Isis Reports Financial Results And Highlights For Second Quarter 2015 15Isis Reports Financial Results And Highlights For Second Quarter 2015 16
... 9, 2011 Lpath, Inc. (OTC: LPTN), the category ... 5th RetailInvestorConferences.com presentation is available for on-demand viewing. ... "register/ watch event now" button. Lpath, Inc.,s ... may download shareholder materials from the "virtual trade booth" ...
... Tenn., May 9, 2011 Muenster Memorial Hospital, ... serving a bi-county area north of Denton, Texas, ... Record as Muenster,s EMR solution, Michael Kent, Muenster ... ) (Logo: http://photos.prnewswire.com/prnh/20110503/CL93887LOGO-b ) ...
Cached Medicine Technology:Lpath, Inc. CEO Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com 2Lpath, Inc. CEO Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com 3Muenster Memorial Hospital Selects ChartSmart emr® 2Muenster Memorial Hospital Selects ChartSmart emr® 3
(Date:8/4/2015)... ... August 04, 2015 , ... Members receiving care from ... metrics – at a cost that is nine percent lower -- than those members ... Shield of New Jersey’s patient-centered programs. , “The promise of patient-centered, or value-based, ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... up-to-date immunizations, especially those entering kindergarten. All required immunizations are covered for members ... which means that children who aren’t caught up with their immunizations may not ...
(Date:8/4/2015)... New York (PRWEB) , ... August 04, 2015 ... ... exceptional dietary supplement manufacturing, label design, product packaging, and fulfillment services, joined over ... Challenge. The event was held on Tuesday, July 28th at Jones Beach ...
(Date:8/4/2015)... ... ... Mesothelioma researchers in Australia have some promising news for ... option. Surviving Mesothelioma has just posted an article on the new research. Click ... of New South Wales, peritoneal mesothelioma patients can undergo retreatment with ...
(Date:8/4/2015)... ... August 04, 2015 , ... Providigm, LLC, a ... facilities, today announced details of the Advanced level of their national accreditation for ... QAPI Accreditation program , introduced in 2013, is based on standards for ...
Breaking Medicine News(10 mins):Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 2Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 3Health News:Buckeye Health Plan Reminds Parents to Keep Immunizations In Mind As School Year Kicks Off 2Health News:NutraScience Labs "Steps Up" to the 2015 Marcum Workplace Challenge 2Health News:New Research Reveals Some Patients Experience Extended Mesothelioma Survival with Repeat Treatment, According to Surviving Mesothelioma 2Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 2Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 3
... , LOS ANGELES , Jan. 16 ... survivors, the Service Employees International Union (SEIU) has entered into an ... relief efforts. , As many as 600 SEIU members, many ... volunteered to be part of an emergency response in Haiti ...
... WASHINGTON , Jan. 16 The ... is sending additional specialists to Haiti to help ... of individuals in makeshift medical facilities are in dire need ... ) , Global Health Bureau,s Clydette Powell ...
... , PHILADELPHIA , Jan. 16 ... Haiti this week and CBS News flew to the ... has an agreement with the United Nations Mission Hospital in ...  The hospital called, asking for additional blood because of the medical ...
... treatments for other conditions, such as anemia, researchers say ... cells can produce molecules that control blood pressure in ... a number of medical conditions, researchers report. , "Our ... approach," said Dr. Jonathan Vogel, a senior investigator in ...
... MARINA DEL RAY, Calif., Jan. 15 Dr. Richard ... announce he is sending much needed assistance to the Haitian earthquake victims ... and staff are leaving Jan 25 & 26. The fund ... able to treat hundreds of patients a day at their clinic. The ...
... , WASHINGTON , Jan. ... America (LFA), along with 22 national organizations, attended the ... care provider education initiative to improve lupus diagnosis, treatment, ... American College of Rheumatology offices in Atlanta, Georgia ...
Cached Medicine News:Health News:International Medical Corps Partners with Service Employees International Union to Provide Aid to Haiti's Earthquake Survivors 2Health News:USAID's Global Health Bureau Responds to Haiti's Medical Crisis 2Health News:USAID's Global Health Bureau Responds to Haiti's Medical Crisis 3Health News:CBS News Helps Red Cross Transport Blood into Haiti 2Health News:CBS News Helps Red Cross Transport Blood into Haiti 3Health News:Bioengineered Skin Grafts Control Blood Pressure in Mice 2Health News:Bioengineered Skin Grafts Control Blood Pressure in Mice 3Health News:Heritage Provider Network, Dr. Richard Merkin, Comes to the Aid of Haitian Earthquake Victims 2Health News:Lupus Foundation of America Collaborates with Federal Agencies and the U.S. Surgeon General's Office to Expand Medical Education on Lupus 2Health News:Lupus Foundation of America Collaborates with Federal Agencies and the U.S. Surgeon General's Office to Expand Medical Education on Lupus 3
... neurodiagnostic for basic and advanced ... a large 12.1" XGA (1024 ... and the latest in technology ... speed, advanced NCS capabilities, advanced ...
... is a non-invasive and painless method of ... Cadwell Laboratories manufactures two magnetic stimulation devices, ... Stimulator (HSMS). The Hight Speed ... rates up to 25 Hz at full ...
... illuminated hand-held potential vision tester measures retinal ... glaucoma. Potential vision testing requires two ... or RAM (formerly known as the Illuminated ... (clip with a pinhole disc and hinged ...
... MOBEE headboxes are ... Xltek's line of portable ... with a robust new ... latest software, XLTEK's standard ...
Medicine Products: